Adherence to treatment in adults with cystic fibrosis

Not Applicable

Completed

• Conditions: Specialty: Respiratory disorders, Primary sub-specialty: Respiratory disorders; UKCRC code/ Disease: Respiratory/ Other diseases of the respiratory system; Genetic Diseases; Cystic fibrosis

• Registration Number: ISRCTN13076797
• Lead Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust

Brief Summary

2019 Results article in https://www.ncbi.nlm.nih.gov/pubmed/29886416 results (added 08/05/2019) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/32697197/ results (added 24/07/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34665573/ (added 10/07/2023) 2020 Results article in https://pubmed.ncbi.nlm.nih.gov/33109661/ (added 10/07/2023) 2019 Results article in https://pubmed.ncbi.nlm.nih.gov/30975206/ (added 10/07/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-07
• Study Completion: 2017-04-30
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 61

Inclusion Criteria

1. Diagnosed with CF and within CF registry
2. Aged 16 years and above
3. Taking inhaled mucolytics or antibiotics via a chipped nebuliser (e.g. eTrack or I-Neb or able and willing to take via eTrack or I-Neb)

Exclusion Criteria

1. Post-lung transplant
2. People on the active lung transplant list
3. Patients receiving palliative care, with palliative intent, for whom trial participation could be a burden
4. Participants who lack capacity to give informed consent 5) Participants using dry powder devices to take antibiotics or mucolytics

Study & Design

• Study Type: Interventional
• Study Design: Not specified